The number of people with susceptibility test result for rifampicin in Sao Tome and Principe
Sao Tome and Principe: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile
Latest (2021)
0
Change on year
down 100.0%
World rank
142nd
of 146 countries
All-time high
47.06
in 2018
All-time low
0
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Sao Tome and Principe, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Sao Tome and Principe stood at 0. That is the lowest value across all 5 years on record.
That represents a change of down 100.0% on the previous year and down 100.0% over five years.
That places Sao Tome and Principe 142nd out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Sao Tome and Principe, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 15.22 | — |
| 2018 | 47.06 | +209.2% |
| 2019 | 0 | -100.0% |
| 2020 | 2.08 | — |
| 2021 | 0 | -100.0% |
Sao Tome and Principe compared with similar countries
- Sao Tome and Principe's 0 is below the median for lower middle income countries, which is 78.77. (32 countries reporting)
- Sao Tome and Principe's 0 is below the median for Sub-Saharan Africa, which is 61.16. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 20.76 | 0 | 47.06 | 3 |
| 2020s | 1.04 | 0 | 2.08 | 2 |
Countries ranked near Sao Tome and Principe
- 139 Central African Republic 9.75 compare
- 140 Venezuela 3.31 compare
- 141 France 1.45 compare
- 142 South Sudan 0 compare
- 142 Grenada 0 compare
- 142 Vanuatu 0 compare
- 142 Mauritania 0 compare
More health data for Sao Tome and Principe
- Un projection of annual infant deaths, annual growth rate -6.25 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 793.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 15 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2021)
- Population ages 00-04, female, annual growth rate 1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0651 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Sao Tome and Principe?
- The number of people with susceptibility test result for rifampicin in Sao Tome and Principe was 0 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Sao Tome and Principe?
- The highest recorded value was 47.06 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Sao Tome and Principe?
- The lowest recorded value was 0 in 2019.
- How does Sao Tome and Principe rank for the number of people with susceptibility test result for rifampicin?
- Sao Tome and Principe ranks 142nd out of 146 countries with data for 2021.
- Where does this Sao Tome and Principe data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).